Pharma / biotech can save 3o% on your seat with super early-bird pricing ($1100) + 3-for-the-price-of-2 group packs available. Offer ends in:
Day(s)
:
Hour(s)
:
Minute(s)
:
Second(s)
The next generation of drug product development
and manufacturing technology is here…
Now in it’s 13th year, the popular 026 CRBE Summit East – Innovations in Controlled Release, Bioavailability Enhancement & Nano Drug Delivery Systems returns this May.
Connect with 160+ senior drug development innovators and uncover industry’s latest formulation, product development and delivery technologies for improving performance and manufacuring capabilities.
2026’s Summit covers Controlled & Modified Drug Release, Drug Bioavailability Enhancement and Nano Drug Delivery technologies and capabilities.
✅ 2 full tracks of technical talks, panels and thought-provoking discussion sessions
✅ Network with 100’s of senior development, formulation and manufacturing attendees and solution providers
✅ Multiple exhibits, banquet lunches and dinners, workshops, exhibits, champagne giveaways and networking receptions
✅ Access all sessions post-Summit on-demand so you can relive your best moments
✅ Be part of our community of drug product development experts which will open many doors in the future.
40+
Industry-led Speakers
160+
Senior Attendees
2
Tracked Streams
14+
Networking Hours
18
Solution Providers
2026 Speakers Include
Mansoor A. Khan, PhD
Dean & Distinguished Professor of Pharmaceutical Sciences & Ex CDER FDA
Texas A&M University
James DiNunzio, PhD
Executive Director & Distinguished Scientist
Merck & Co.
Indrajit Ghosh, PhD
Scientific Director, Biologics Product Development
Bristol Myers Squibb
Liangfang Zhang, PhD
Professor, Department of Chemical and Nano Engineering
University of California San Diego
Karunakar Sukuru, PhD
Global Vice President, Pharma Product Development & Head of Scientific Advisory
Catalent Pharma Services
Shabbir Lobo, PhD
Staff Scientist, Global Innovations and Product Development
Bayer
Amit Kale, PhD
Executive Director, CMC/Drug Product, Pharmaceutical Development
Relay Therapeutics
Michael Grass, PhD
Senior Director, Product Innovation
Bend Bioscience
Lipa Shah, PhD
Director, Novel Delivery Technologies
Novartis
Dave Miller, PhD
Chief Scientific Officer
AustinPx
Anjali Agrawal, PhD
Executive Director, CMC & Product Supply
Novo Nordisk
Deb Das, PhD
Senior Associate Director & Science Fellow, Innovation & Product Development Lead
Bayer
Kush Patel, PhD
Research Fellow, Oral Product Development
Pfizer
Nicole Jarvi, PhD
Senior Scientist - Biologics & Biopharmaceutics, Sterile Product Development
Merck & Co.
Freddy Arce, PhD
Senior Scientist, Oral Solid Dosage
Bristol Myers Squibb
Nick DiFranco, MEN
Senior Marketing Manager, Pharmaceutical Division
Gattefossé USA
Andrew Leithead, PhD
Associate Principal Scientist, Discovery Pharmaceutical Sciences
Merck
Dhaval Patel, PhD
Executive Director & Head, Formulation Development
PTC Therapeutics, Inc.
David Schoneker, PhD
President
Black Diamond Regulatory Consulting, LLC
Wesley Tatum, PhD
Senior Principal Engineer
Serán BioScience
Vivek Gupta, PhD
Associate Professor, Pharmaceutical Sciences
St. John’s University
Zoe Wen, PhD
Principal Scientist, Formulation Development
Sanofi
Ali Rajabi-Siahboomi, PhD
Advisory, Leadership & innovation
ALi Pharma Solutions, LLC
Sebastian Escotet, PhD
Principal Scientist, Oral Formulation Sciences
Merck & Co.
Controlled and Modified Release
- Oral Drug Delivery Systems
- Long Acting Injectable Drug Delivery Systems
- Transdermal Drug Delivery Systems
- Modified release coating systems
- Biodegradable and Biocompatible Polymers
- Nanotechnology in Controlled Release
- Pulmonary Drug Delivery Systems
- The Role of Controlled Release in Optimizing Therapeutic Outcomes
- Patient Centric / Pediatric Dose Development
- 3D Printing in Controlled and Modified Release
- Regulatory considerations
- Continuous manufacturing of Controlled and Modified Release products
- Continuous modified release coating systems
- Continuous long-acting microsphere manufacturing
Bioavailability Enhancement
- Formulation strategies for improved absorption of poorly soluble and/or poorly permeable drugs
Solubility and dissolution enhancement techniques:
– Lipid-Based formulations
– Micronization
– Nanomedicine
– Nanocarriers
– Spray Dried Dispersions (SDD)
– Hot Melt Extrusion (HME)
– Kinetisol - Biopharmaceutics classification system (BCS) and its implications
- In vitro-in vivo correlations (IVIVCs)
- Continuous manufacturing technologies for Bioavailability Enhancement
Continuous Manufacturing
- Continuous biopharmaceutical manufacturing
- Continuous manufacturing of oral solids
- Spray Drying and Continuous Manufacturing of Pharmaceutical Materials
- Melt Extrusion and Continuous Manufacturing of Pharmaceutical Materials
- Continuous reactors for pharmaceutical manufacturing
- Recent regulatory status in continuous manufacturing
- Continuous Manufacturing equipment change over time
- Capacity planning for continuous pharmaceutical manufacturing facilities
- Continuous modified release coating equipment
- Continuous fluid-bed coating
- Continuous tablet-coating
- Continuous lyophilization
2026 Sponsors & Exhibitors
Download The Controlled Release Previous Attendee List
Partnering with the 2026 Summit will also help you:
- Enhance commercial relationships with existing clients through platform interaction, meetings, and discussing the latest opportunities
- Raise your brand awareness to a captive and engaging audience, which most-of-all encompasses decision-making criteria
- Elevate your profile amongst industry peers and developing a contact base through 1-2-1 networking sessions
- Generate direct new business opportunities from senior-level attendees with decision-making criteria currently sourcing drug product development solutions
"*" indicates required fields
Registration Pricing:
Super Early-Bird
Register Before April 17, 2026
Pharma / Biotech
$1100
3-for-2 Group Pack
CDMO / Vendor Registration
$3500
On-Demand
$595
Early-Bird Rate
Register Before May 8, 2026
Regular Attendance
$1400
3-for-2 Group Pack
$2800
CDMO / Vendor Registration
On-Demand
$595
ONSITE PRICING
Register May 9, 2026 Onwards
Regular Attendance
$1600
3-for-2 Group Pack
$3200
CDMO / Vendor Registration
On-Demand
$795
Access the 2025 Summit On-Demand Content for Free
The 2025 Summit highlighted innovative strategies, approaches and platforms designed to overcome drug product development and delivery . From cutting-edge techniques such as electrospinning, mesoporous silica technology, 3D printing, physiochemical optimization, amorphous nanoparticle engineering, to sophisticated pharmacokinetic modeling, the Summit detailed a wide range of approaches. The ultimate objective is to help you save valuable time and resources while expediting the development of yor drug products.
"*" indicates required fields